2023
DOI: 10.1016/j.cej.2023.141929
|View full text |Cite
|
Sign up to set email alerts
|

A biomimetic study of aliphatic and aromatic dicarboxylic acids engineered β-CD targeted for intestinal maladies

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
5
1

Relationship

0
6

Authors

Journals

citations
Cited by 7 publications
(1 citation statement)
references
References 43 publications
0
1
0
Order By: Relevance
“…The encapsulation of EO in CDs is a reversal process, which means captured compounds could also be released externally. HCl buffer (pH = 1.2) and phosphate buffer (pH = 6.8) are useful for in vivo models because these values represent the gastric environment and duodenal, respectively [61] . The release profile of α, β, and γ-CD ICs in different pH conditions are shown in Fig.…”
Section: Resultsmentioning
confidence: 99%
“…The encapsulation of EO in CDs is a reversal process, which means captured compounds could also be released externally. HCl buffer (pH = 1.2) and phosphate buffer (pH = 6.8) are useful for in vivo models because these values represent the gastric environment and duodenal, respectively [61] . The release profile of α, β, and γ-CD ICs in different pH conditions are shown in Fig.…”
Section: Resultsmentioning
confidence: 99%